AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05722054 — intervention group
Intervention type: OTHER
Intervention: Diagnostic tests
Description: Blood smears; rapid diagnostic tests; complete blood counts with differential; leucoconcentration; urine examination; nasal/throat swabs, stool examination.
Study NCT05722054 — intervention group
Intervention type: OTHER
Intervention: Equilibrate diet
Description: Nutritionally-balanced Alimentation
Study NCT03024177 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vapendavir
Description: Vapendavir Tablets, 264 mg
Study NCT03024177 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Tablet
Description: Vapendavir 264 mg matching tablets
Study NCT04808622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trans-Sodium Crocetinate
Description: TSC given as a one-time IV bolus injection
Study NCT04808622 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo normal saline given as a one-time 7 mL one-time IV bolus injection
Study NCT06072443 — intervention group
Intervention type: BEHAVIORAL
Intervention: Digital Health Companion (mobile App)
Description: Participants will complete education modules, health literacy evaluations, and PRO assessments in the Digital Health Companion.
Study NCT05325697 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Intervention consisting of a multicomponent exercise program combined with an oral nutritional supplement
Description: The multicomponent exercise program to prevent frailty and risk of falls (Vivifrail) was developed by a European expert group co-funded by the ERASMUS+ programm of the European Union. The program consists of a screening and a subsequent 12-week exercise program. The screening classifies individuals into four categories: disabled, frail, pre-frail, or robust and the difficulty of the program's exercises is adapted to the categories and it includes endurance, balance, and resistance training as well as stretching exercises. This exercise program will be combined with an oral nutritional supplement (Moltein®Plus), which was specifically designed to promote muscle health in elderly people. Moltein®Plus is completely balanced oral nutrition supplement made from whey protein fortified with leucine. Enriching dietary protein with leucine allows to maximize muscle protein synthesis rates without calling for very high protein doses, which are difficult to ingest for older individuals.
Study NCT06321549 — intervention group
Intervention type: OTHER
Intervention: The reference point of minimally invasive mastectomy procedure conducted
Description: November 2018 as a temporal reference point was predicated on the milestone of the medical center's inaugural minimally invasive mastectomy procedure conducted
Study NCT04782388 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alprazolam
Description: Study participants will receive Staccato alprazolam at prespecified time-point.
Study NCT04782388 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Study participants will receive Staccato placebo at prespecified time-point.
Study NCT05615532 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3209590 (SC)
Description: Administered SC.
Study NCT05615532 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3209590 (IV)
Description: Administered IV.
Study NCT06375889 — intervention group
Intervention type: OTHER
Intervention: blood test
Description: During the routine blood test of the patient, 5 more tubes of 2.7 milliliters (mL) will be collected to make Platelet Activation Analysis
Study NCT05532748 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Respiratory exercise protocol with the modified Pachon's incentive
Description: With the participant sitting on a chair, with their back against the backrest, they will hold the device with the hand that is most comfortable for them and place the mouthpiece in their mouth, ensuring a correct seal with their lips.~You will be asked to take a slow, deep breath, fully stretching the condom, and hold your breath for at least 5 seconds. Expiration will be performed passively through the device without removing it from the mouth and without performing any forced maneuver.~There will be 3 series of 10 breaths with a 1-minute rest between series. The total number of breaths for the entire session will be 30; the maneuver will end once the series and repetitions are finished. You will be asked to remove the mouthpiece from your mouth and breathe for 3 minutes at a gentle intensity through your nose without extra effort.~All these instructions will be explained through a video.
Study NCT05532748 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Respiratory exercise protocol with the modified Pachon's incentive
Description: With the participant sitting on a chair, with their back against the backrest, they will hold the device with the hand that is most comfortable for them and place the mouthpiece in their mouth, ensuring a correct seal with their lips.~You will be asked to take a slow, deep breath, fully stretching the condom, and hold your breath for at least 5 seconds. Expiration will be performed passively through the device without removing it from the mouth and without performing any forced maneuver.~There will be 3 series of 10 breaths with a 1-minute rest between series. The total number of breaths for the entire session will be 30; the maneuver will end once the series and repetitions are finished. You will be asked to remove the mouthpiece from your mouth and breathe for 3 minutes at a gentle intensity through your nose without extra effort.~All these instructions will be explained through a video.
Study NCT05532748 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Respiratory exercise protocol with Branded respiratory incentive, Triflo II®
Description: With the participant sitting on a chair, with their back against the backrest, they will hold the device with the hand that is most comfortable for them and place the mouthpiece in their mouth, ensuring a correct seal with their lips.~You will be asked to take a smooth deep breath lifting as many spheres as you can and hold your breath for at least 5 seconds. Expiration will be performed passively through the device without removing it from the mouth and without performing any forced maneuver.~There will be 3 series of 10 breaths with a 1-minute rest between series. The total number of breaths for the entire session will be 30; the maneuver will end once the series and repetitions are finished. You will be asked to remove the mouthpiece from your mouth and breathe gently through your nose for 3 minutes without extra effort.~All these instructions will be explained through a video.
Study NCT05532748 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Respiratory exercise protocol with Branded respiratory incentive, Triflo II®
Description: With the participant sitting on a chair, with their back against the backrest, they will hold the device with the hand that is most comfortable for them and place the mouthpiece in their mouth, ensuring a correct seal with their lips.~You will be asked to take a smooth deep breath lifting as many spheres as you can and hold your breath for at least 5 seconds. Expiration will be performed passively through the device without removing it from the mouth and without performing any forced maneuver.~There will be 3 series of 10 breaths with a 1-minute rest between series. The total number of breaths for the entire session will be 30; the maneuver will end once the series and repetitions are finished. You will be asked to remove the mouthpiece from your mouth and breathe gently through your nose for 3 minutes without extra effort.~All these instructions will be explained through a video.
Study NCT05221463 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video-assisted breastfeeding training
Description: Breastfeeding training was given to the experimental group for 3 days by means of the training material prepared by the training nurse of the hospital about breast milk and breastfeeding and routinely used by nurses in breast milk training in neonatal units. During the training, mothers were allowed to watch breast milk and breastfeeding training videos. On the third day after the training, feedback was received from the applications in the video regarding the knowledge and skills of the mother, and the mother's questions were answered.
Study NCT05221463 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: The hospital's routine general breastfeeding training
Description: The control group was given the hospital's general breastfeeding training for 3 days by means of the training material prepared by the training nurse of the hospital about breast milk and breastfeeding and used routinely by nurses in breast milk training in neonatal units, and the questions of the mother were answered. The mothers in this group performed the routine breastfeeding process and no other interventions were made.
Study NCT05828043 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multi-domain intervention
Description: Each session comprises of 45 minutes physical fitness activities targeting on muscle strength, balance, and flexibility; 1-hour cognitive training primarily on reasoning and memory exercises; and 15-minute for nutritional advices based on national diet guidelines for older adults
Study NCT04900922 — intervention group
Intervention type: DEVICE
Intervention: isokinetic dynamometer
Description: We will use an isokinetic dynamometer to conduct the concentric isokinetic fatigue protocol. The start position is shoulder abduction 90°, elbow flexion 90°and range of motion is set from 0 ° (internal rotation) to 90 ° (external rotation) under 120°/s. To calculate maximum torque of shoulder external and internal rotation, the subject will perform maximum isokinetic test 5 times before fatigue. Fatigue protocol include 10 sets, and each set include 32 repetitions with 30 seconds of rest between sets. The fatigue protocol will be stopped under three conditions: 1. the torque decreases 50% of maximum torque three times in one set or 2.rating of perceived exertion (RPE) abrove 15 and players can not perform the fatigue protocol or 3. finish the whole test.
Study NCT06235931 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Darcilide +AI (letrozole/anastrozole/Exemestane) + pyrrotinib
Description: Darcilie: 125mg orally once a day, taken for 21 days and stopped for 7 days, 28 days as a cycle.~AI: Letrozole: 2.5mg orally once daily, or anastrozole 1mg orally once daily, or exemestane 25mg orally once daily.~Pyrrotinib: Initial dose of 240mg in the first week, if diarrhea and other side effects can be tolerated, 320 mg can be added in the second week, once a day, oral administration within 30 minutes after breakfast, 21 days for 1 cycle~All investigational drugs should be used for disease progression or when patients have an intolerable adverse reaction or are withdrawn from the study for other reasons.~Oral pyrrotinib is recommended along with prophylactic antidiarrheal medication. Antidiarrheal regimen 1: Oral imodium (2 tablets/times, 2 times a day) from the first week, 1 tablet, 2 times a day from the second week. Antidiarrheal regimen 2: montmorillonite powder (3 times a day, 1 pack/time)+ whole intestine sheng (3 pills/time 2 times a day).
Study NCT06233721 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Online education
Description: Education content was prepared by the researchers by reviewing the literature. Education content included topics such as oral anticoagulant (OAC) medication introduction, OAC medication use, duration of use, most frequently seen side effects, interaction with other medications and foods, and points to consider while using the medication. While preparing the education content, expert opinions of five nurse academicians were taken. Evaluation of expert opinion was made through the form for Evaluation of the Appropriateness of Printed Materials and Discern. This education content created was provided to the face-to-face and online education groups in one session. Education sessions lasted approximately for 25-30 minutes.
Study NCT06233721 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Face-to-face education
Description: Education content was prepared by the researchers by reviewing the literature. Education content included topics such as OAC medication introduction, OAC medication use, duration of use, most frequently seen side effects, interaction with other medications and foods, and points to consider while using the medication. While preparing the education content, expert opinions of five nurse academicians were taken. Evaluation of expert opinion was made through the form for Evaluation of the Appropriateness of Printed Materials and Discern. This education content created was provided to the face-to-face and online education groups in one session. Education sessions lasted approximately for 25-30 minutes.
Study NCT05532254 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aripiprazole 10 mg tablet
Description: an immediate-release tablet containing 10 mg Aripiprazole
Study NCT05532254 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Abilify® 10 mg tablet
Description: an immediate-release tablet containing 10 mg Aripiprazole
Study NCT06494605 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Early Start Denver Model (ESDM)
Description: The Early Start Denver Model (ESDM) is an early naturalistic and behavioural intervention for children with initial signs of neurodivergence or on the autism spectrum between the ages of 12-48 months. This early intervention aims to increase the rates of development in several domains and to decrease the characteristics of autism conditions that hinder children's ability to learn from everyday experiences and interactions.
Study NCT04756856 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Muscle-target oral nutritional supplementation
Description: Patients will receive daily for 12 weeks two servings (40 grams each) of powder (Fortifit; Nutricia) which has to be dissolved in 125 ml of water. Per serving, 20 g whey protein, 3 g total leucine, 9 g carbohydrates, 3 g fat, and 800 IU vitamin D. Patients will be also followed for 12 weeks after the suspension of supplementation.
Study NCT05251480 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: debridement, wound dressings, offloading
Study NCT05251480 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DermGEN™
Description: Decellularized human dermal matrix created from donated human skin
Study NCT04646421 — intervention group
Intervention type: BEHAVIORAL
Intervention: Motivational telephone intervention
Description: Motivational telephone intervention to high-risk gamblers, aiming to stimulate them to reduce gambling, quit gambling, or to seek peer support or treatment.
Study NCT06530147 — intervention group
Intervention type: OTHER
Intervention: Transversalis Fascia Plane Block
Description: One-side ultrasound (US)-guided Transversalis fascia plane (TFP) block with 0.25% bupivacaine will performe after placement laryngeal mask airway before surgery.
Study NCT06530147 — intervention group
Intervention type: OTHER
Intervention: Transversus Abdominis Plane Block
Description: One-side ultrasound (US)-guided Transversus abdominis plane (TAP) block with 0.25% bupivacaine will performe after placement laryngeal mask airway before surgery.
Study NCT05365425 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Choline fenofibrate
Description: choline fenofibrate 178.8mg (135mg as fenofibric acid)
Study NCT05066698 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ST266
Description: Topical ocular application: one drop four times a day for eight weeks
Study NCT05066698 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: 0.67% Sodium Chloride Ophthalmic Solution
Description: Topical ocular application: one drop four times a day for eight weeks
Study NCT05066698 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Open-label ST266
Description: Open label extension for non-healers after completion of double-blind treatment phase: topical ocular application of one drop four times a day for eight weeks
Study NCT05066698 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Open-label ST266
Description: Open label extension for non-healers after completion of double-blind treatment phase: topical ocular application of one drop four times a day for eight weeks
Study NCT04845633 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Evaluation of the Effectiveness of Conventional Toothbrush in Dental Plaque Control in Healthy Children
Description: Healthy children will be given conventional toothbrush.Plaque scores in groups will be assess pre-brushing and post-brushing in baseline, a week, and after 3 weeks by using the Turesky Modification of the Quigley-Hein Plaque Index (TMQHPI) for both buccal and lingual surfaces
Study NCT04845633 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Evaluation of the Effectiveness of Customized Handle Toothbrush in Dental Plaque Control in Healthy Children
Description: Healthy children will be given toothbrush with Customized Handle.Plaque scores in groups will be assess pre-brushing and post-brushing in baseline, a week, and after 3 weeks by using the Turesky Modification of the Quigley-Hein Plaque Index (TMQHPI) for both buccal and lingual surfaces
Study NCT04845633 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Evaluation of the Effectiveness of Conventional Toothbrush in Dental Plaque Control in Children with Down Syndrome
Description: Children with Down syndrome will be given conventional toothbrush.Plaque scores in groups will be assess pre-brushing and post-brushing in baseline, a week, and after 3 week by using the Turesky Modification of the Quigley-Hein Plaque Index (TMQHPI) for both buccal and lingual surfaces
Study NCT04845633 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Evaluation of the Effectiveness of Customized Handle Toothbrush in Dental Plaque Control in Children with Down Syndrome
Description: Children with Down syndrome will be given toothbrush with Customized Handle.Plaque scores in groups will be assess pre-brushing and post-brushing in baseline, a week, and after 3 weeks by using the Turesky Modification of the Quigley-Hein Plaque Index (TMQHPI) for both buccal and lingual surfaces
Study NCT05098613 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CD19x22 CAR T Cells
Description: Autologous peripheral blood mononuclear cells transduced with CD19x22 CAR T lentiviral vector.
Study NCT05509985 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ASKG315
Description: Injection with dose escalation stage of 3mg up to 45mg as well as dose expansion stage with recommended dose level from dose escalation stage.
Study NCT05100485 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Esophagogasrtoduodendoscopy
Description: Esophagogasrtoduodendoscopy was used to detech the presence of varices.
Study NCT05100485 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Hepatic venous pressure gradient
Description: A method used to eveluate the portal pressure
Study NCT04867889 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: iTBS (intermittent theta-burst stimulation)
Description: The iTBS treatment is a type of rTMS (repetitive transcranial magnetic stimulation), delivered with MagPro X100 stimulator and a Cool-B65 A/P coil or a conventional cool-B65 coil.~The iTBS treatment is applied to over the dorsolateral prefrontal cortex using a standardized measuring of the anatomical landmark F3 from the 10-20 positioning system. The coil is positioned with the handle at in a 45 degree angle from the midline. The non-shielded side of the cool-B65 A/P coil is placed towards the patient, or if using the cool-B65 coil the centre of the butterfly is placed towards the patient head
Study NCT04867889 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham iTBS
Description: The sham iTBS is delivered with MagPro X100 stimulator and a Cool-B65 A/P coil.~The coil is placed over the dorsolateral prefrontal cortex using a standardized measuring of the anatomical landmark F3 from the 10-20 positioning system. The coil is positioned with the handle at in a 45 degree angle from the midline. For all patients electrodes for transcutaneous electrical nerve stimulation (TENS) are applied and if the patient is randomized to sham treatment the shielded side of the coil will be pointing towards the patient's head and there will be a weak TENS current applied instead synchoronously. If the cool-B65 is used the coil is instead angled 90 degrees delivering the pulses into air instead
Study NCT05429151 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acyclovir 250mg Powder for Solution for Infusion, each vial contains 250mg of acyclovir as the sodium salt, Chandra Bhagat Pharma Pvt. Ltd andcandida antigen
Description: Group 1: will be treated with intralesional injection of acyclovir (Acyclovir 250mg Powder for Solution for Infusion, each vial contains 250mg of acyclovir as the sodium salt, Chandra Bhagat Pharma Pvt. Ltd) 250 mg acyclovir vial diluted with 3.5 ml saline to get approximately 70 mg/ml solution. During the study, the dosage of the drug and frequency of treatment were uniform in all patients. The base of each wart was injected with 0.1 ml of intralesional acyclovir (70 mg/ml) using an insulin syringe (29 Gage × 0.5-in) every 2 weeks until the resolution of warts or for a maximum of 5 sessions~Group 2: will be treated by intralesional Candida antigen injection (candida antigen ) at a dose of 0.2 mL. injected into the largest wart using an insulin syringe (29 Gage × 0.5-in) every 2 weeks until complete clearance of warts or for a maximum of 5 treatment sessions.
Study NCT06227663 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: KOALOU(®) digital application
Description: Digital app that prepares children for the ambulatory surgery care pathway by assessing their anxiety and educating them about anesthesia and surgery
Study NCT05539859 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic surgery
Description: Subjects will receive surgical hematoma evacuation using neuroendoscope, followed by medical management
Study NCT05539859 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Medical management
Description: Subjects will initially receive the standard medical therapies for the treatment of intracerebral hemorrhage, according to the latest available guideline.
Study NCT06010069 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: body temperature measurament
Description: body temperature of every patient was measured with tympanic thermometer during surgical procedure